MAT2A inhibitor (Anagenex)

N/A

Report date: 2025/06/11 10:38:57
NME

Base Information

Drug NameMAT2A inhibitor (Anagenex)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionS-adenosylmethionine synthase isoform type-2 inhibitors
TargetsS-adenosylmethionine synthase isoform type-2
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnagenex Inc
China Registration ClassN/A

Develop Information

Active CompaniesAnagenex Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A